SUBCLINICAL HYPERTHYROIDISM AND OVERT HYPERTHYROIDISM AS A RISK FACTORS FOR ATRIAL FIBRILLATION IN AL- NASIRIYAH CITY
Abstract
Background Atrial fibrillation is a well known manifestation of hyperthyroidism , we studied whether subclinical hyperthyroidism in clinically euothyroid persons is a risk factor for atrial fibrillation . Method we studied 267 persons , the subject was classified into 3 groups according to the serum TSH group I: ( 174 ) persons compromised those with normal values of serum TSH ( 0.25 – 5 μU/ml) and T3 , T4 within normal limit , this group considered as control group. group II: ( 61 ) persons those with low serum TSH ( < 0.25 μU/ml) and with elevated serum T3 and T4 i.e overt hyperthyroidism. group III: ( 32 ) persons those with low serum TSH ( < 0.25 μU/ml ) and T3 and T4 within normal limit i. e. sub clinical hyperthyroidism . Result: Atrial fibrillation ( AF ) was presented in 4 only from 174 with a percent of ( 2.3 %) in group I ,but 9 only from 61 persons with a percent of ( 13.8 %) were presented in group II , while 4 only from 32 persons with a percent of ( 12.7 %) in group III . There is significant difference ( P < 0.01 ) between group I when it compared with other groups . Conclusion: Low serum thyrotropin concentration is associated with more than 5 fold higher likely hood for the presence of AF with no significance difference between subclinical and overt hyperthyroidism .References
Banach M, Misztal M, Goch A, Rysz J, Goch JH. Predictors of atrial fibrillation in patients following isolated surgical revascularization. A metaanalysis of 9 studies with 28 786 patients. Arch Med Sci. 2007;3:229–239.
Mariscalco G, Klersy C, Zanobini M, Banach M, Ferrarese S, Borsani P, Cantore C, Biglioli P, Sala A. Atrial Fibrillation After Isolated Coronary Surgery Affects Late Survival. Circulation. 2008;118:1612–18.
Staffurt JS, Gibberd JS, Tang FS. Arterial embolism in thyrotoxicosis with atrial fibrillation. Br Med J. 1977;2:688–690.
Agata BDimitri P M, Jacek R, and Maciej B The mechanisms of atrial fibrillation in hyperthyroidism Thyroid Res. 2009; 2: 4.
Jayaprasad N, Johnson F Atrial Fibrillation and Hyperthyroidism Indian Pacing Electrophysiol J. 2005 Oct–Dec; 5(4): 305–311.
Staffurth JS, Gibberd JS, Tang FS, et al. Arterial embolism in thyrotoxicosis with atrial fibrillation. Br Med J. 1977;2:688–690.
Lazar MA. Thyroid hormone receptors: multiple forms, multiple possibilities. Endocr Rev. 1993;24:184–193.
Shimoni Y, Severson DL. Thyroid status and potassium currents in rat ventricular myocytes. Am J Physiol. 1995;268:H576–H583.
Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344:501–509.
Ojamaa K, Klemperer JD, Klein I. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid. 1996;6:505–512.
Beirsack H.J. Hotze A. The clinician and the thyroid. Eur. J. Nucl. Med. 1991, 18,761-778.
Jyothis T G, Jonathan C T, Bruce M, Maurice P , and Vijay J,Atrial fibrillation associated with a thyroid stimulating hormone-secreting adenoma of the pituitary gland leading to a presentation of acute cardiac decompensation: A case report, Med Case Reports. 2008; 2: 67.
Welborn TA, Cumpston GN, Cullen KJ, Curnow DH, McCall MG, Stenhouse NS. The prevalence of coronary heart disease and associated factors in an Australian rural community. Am J Epidemiol. 1969;89:521-536.
Sawin CT, Geller A, Wolf P, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249–1252.
Irwin K, Kaie OThyroid Hormone and the Cardiovascular System NEJM , 2001,Volume 344:501-509
Forfar J, Miller HC, Toft AD. Occult thyrotoxicosis: a reversible cause of "idiopathic" atrial fibrillation. Am J Cardiol. 1979;44:9–12.
Fazio S, Palmieri EA, Lombardi G, Biondi B. Effects of Thyroid Hormone on the Cardiovascular System. Recent Progr Horm Res. 2004;59:31–50.
Dillmann WH. Biochemical basis of thyroid hormone action in the heart. Am J Med. 1990;88:626–630.
Krahn AD, Klein GJ, Kerr CR, et al. How useful is thyroid function testing in patients with recent-onset atrial fibrillation? Arch Intern Med 1996;156:2221-2224.
Klein I, Ojamaa K. Thyrotoxicosis and the heart. Endocrinol Metab Clin North Am 1998;27:51-62.
Gilligan DM, Ellenbogen KA, Epstein AE. The management of atrial fibrillation. Am J Med 1996;101:413-421.